FDA EIR - Abbott Laboratories - September 24, 2021

FDA EIR for Abbott Laboratories on September 24, 2021. Product: N/A. Access full analysis and detailed observations.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA EIR for Abbott Laboratories on September 24, 2021. Product: N/A. Access full analysis and detailed observations.

Violation Codes

FD&C Act 801(a)(3)

21 CFR 16

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Abbott Laboratories

Inspection Date

September 24, 2021

Product Type

People

ID: 5852760e-4717-4251-9e6f-60279ba8d184

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox